Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

BACKGROUND: Asthma is a highly prevalent chronic inflammatory airways disease, with a considerable impact on quality of life (QoL). To express the effects of asthma on patients’ subjective experience, patient-reported outcomes (PROs) represent an important instrument. The asthma QoL questionnaire (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Giorgio Lorenzo, Di Matteo, Sergio, Martinotti, Chiara, Oselin, Martina, Valentino, Maria Chiara, Bruno, Giacomo Matteo, Pitotti, Claudia, Menzella, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492364/
https://www.ncbi.nlm.nih.gov/pubmed/31035904
http://dx.doi.org/10.1177/1753466619841350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492364/
https://www.ncbi.nlm.nih.gov/pubmed/31035904
http://dx.doi.org/10.1177/1753466619841350

Ejemplares similares